Carcinoma, Renal Cell: all 1,992 studies
Page 1 of 20. Open to participants first (387), then studies with results posted, then the rest; newest registration first within each.
- A Clinical Study of Ivonescimab in Combination With Cadonilimab or Ipilimumab for Advanced Renal CancerNot yet recruitingNCT07877194Phase 2
- 18F-N230A PET/CT Imaging of Nectin-4 Expression in Renal TumorsRecruitingNCT07875959Not applicable
- 68Ga- and 18F-CAIX PET Imaging StudyNot yet recruitingNCT07875946Early Phase 1
- Plasma DNA Methylation for Preoperative Classification of Renal MassesRecruitingNCT07874542
- A Study of Treatment Delivery Preference In People With Kidney CancerRecruitingNCT07872553Phase 4
- Phase 2a Study to Assess Safety and Efficacy of Two 177Lu-TLX250 Dosing Regimens in Advanced Relapsed or Recurrent ccRCCNot yet recruitingNCT07870746Phase 2
- A Study of CA9-Targeted CAR Macrophage Therapy in Advanced Clear Cell Renal Cell CarcinomaNot yet recruitingNCT07865832Early Phase 1
- Safety and Efficacy Study in Adults With Advanced Solid Tumors Receiving REGN13089-M404-M2980, an Antibody-drug Conjugate That Targets MET Protein on TumorsNot yet recruitingNCT07863024Phase 1/2
- Patient Reported Outcomes and Different Renal Artery Clamping Techniques During Robot Assisted Kidney ResectionNot yet recruitingNCT07853001Not applicable
- A Study to Assess the Safety and Tolerability of BMS-986527 in Participants With Clear Cell Renal Cell Carcinoma (ccRCC)Not yet recruitingNCT07848295Phase 1
- Federated Learning in Renal Tumor ModelNot yet recruitingNCT07841756
- Neoadjuvant Belzutifan Plus Pembrolizumab in High-Risk, Locally Advanced Clear Cell Renal Cell CarcinomaNot yet recruitingNCT07840001Phase 2
- CAIX-targeted PET/CT in Solid TumorsRecruitingNCT07833085Not applicable
- Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALARecruitingNCT07828704Phase 2
- MANTIS-RCC: Toripalimab-Axitinib Induction in TLS-Positive Advanced Non-Clear Cell and Renal Medullary CarcinomasNot yet recruitingNCT07816770Phase 2
- Intensified Monitoring of PhArmacology of Cabozantinib as a Tool for Toxicity Management in Patients With Renal Cell CarcinomaRecruitingNCT07805122Not applicable
- Hyperspectral Imaging in Robot-Assisted Partial NephrectomyRecruitingNCT07803315
- TACTIC-RCC: Toripalimab Plus Axitinib Induction With Selective Deferred Cytoreductive Nephrectomy in TLS-Positive Advanced Clear Cell Renal Cell CarcinomaNot yet recruitingNCT07776717Phase 2
- Clinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer(FASTIL-Renal01)RecruitingNCT07770802Phase 1
- Evaluation of Safety, Pharmacokinetics, Distribution，Radiation Safety and Sensitivity/Specificity of PET/CT Imaging With 68Ga-NYM096 in Participants With IRMNot yet recruitingNCT07768306Phase 1
- Identification and Description of Patients With High-risk Non Metastatic RCCRecruitingNCT07753343
- A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsRecruitingNCT07749586Phase 1/2
- Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell CarcinomaRecruitingNCT07748988Phase 1
- An MRI-Based Study of Intelligent Pathological Subtyping and Grading of Renal TumorsRecruitingNCT07743749
- Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney CancerNot yet recruitingNCT07716735Phase 1
- Ipilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical TrialNot yet recruitingNCT07715565Phase 2
- Comparing Two Weight Loss Programs for the Prevention of Kidney Cancer Progression Among Patients With Small Renal Masses on Active SurveillanceRecruitingNCT07714018Not applicable
- QLESP Block for Pain Control in Robotic Partial NephrectomyRecruitingNCT07704970Not applicable
- A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.Not yet recruitingNCT07689812Not applicable
- Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell CarcinomaNot yet recruitingNCT07689240Phase 3
- A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell CarcinomaRecruitingNCT07688187Phase 1
- Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell CarcinomaNot yet recruitingNCT07686744Phase 1
- Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell CarcinomaRecruitingNCT07680556Not applicable
- Study on MRD Prediction of Efficacy of Toripalimab in the Treatment of High-risk Recurrent Renal CarcinomaRecruitingNCT07657325
- To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal CancerRecruitingNCT07647744Phase 1
- Pilot Study of Intermittent Fasting With Immune Checkpoint InhibitorsNot yet recruitingNCT07645742Not applicable
- A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid TumorsRecruitingNCT07636785Phase 1/2
- Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image GuidanceRecruitingNCT07636148
- Anlotinib + Benmelstobart vs Surgery for Patients With Localized Renal Cell Carcinoma Scheduled to Undergo Partial NephrectomyNot yet recruitingNCT07627464Phase 2
- A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT07623369Phase 1
- Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored StudyEnrolling by invitationNCT07620574Phase 3
- Neoadjuvant PD-L1 Inhibitor Plus Anlotinib for Kidney Preservation in Complex Renal Cell CarcinomaNot yet recruitingNCT07602101Phase 2
- REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell CarcinomaRecruitingNCT07594106Phase 1/2
- Pembrolizumab Plus Belzutifan With or Without Lenvatinib in Localized Renal Cell CarcinomaNot yet recruitingNCT07593040Phase 2
- Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on ImmunotherapyNot yet recruitingNCT07578025Phase 2
- Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialNot yet recruitingNCT07576725Phase 2
- Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell CarcinomaRecruitingNCT07571551Phase 2
- Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell CarcinomaRecruitingNCT07564232Phase 1
- 18F-T2 PET/CT Imaging for CAIX Positive Solid TumorsRecruitingNCT07557225Not applicable
- Pilot Study of Bone Mineral Density Changes During Anti-PD-1 ImmunotherapyRecruitingNCT07555210Not applicable
- Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell CarcinomaRecruitingNCT07551349Phase 1/2
- CAIX PET/ CT Guided Radiation Therapy in CcRCC.RecruitingNCT07540260Not applicable
- Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid TumorsRecruitingNCT07517198Phase 1
- Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT TrialRecruitingNCT07516366Phase 2
- VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell CarcinomaRecruitingNCT07510334Phase 2
- Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell CarcinomaNot yet recruitingNCT07500831Not applicable
- UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell CarcinomaNot yet recruitingNCT07500805Phase 1
- Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial NephrectomyNot yet recruitingNCT07497958Not applicable
- Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCCNot yet recruitingNCT07494435Phase 2
- A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)RecruitingNCT07489495Phase 3
- Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical StudyEnrolling by invitationNCT07488572Phase 2
- Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 InhibitorsRecruitingNCT07485114
- A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological SurgeryNot yet recruitingNCT07480044Not applicable
- SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell CarcinomaNot yet recruitingNCT07470840Phase 2
- An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell CarcinomaRecruitingNCT07469683Phase 2
- Radiofrequency Ablation Multicenter Observational Study in Renal Oncology PatientsNot yet recruitingNCT07465458
- Laparoscopic Versus Open Nephrectomy : Clinical Effectivness and Cost AnalysisRecruitingNCT07461090Not applicable
- Pembrolizumab Plus Lenvatinib in REcurrent ccRCC Patients Failing permbroLizUmab aDjuvant trEatmentNot yet recruitingNCT07460206Phase 2
- A Phase 1 Study of the Safety and Tolerability of CTX-10726RecruitingNCT07419841Phase 1
- Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT StudyRecruitingNCT07405086Phase 4
- CBCT Guided Markerless SBRT for Renal Cell CancerRecruitingNCT07402109Not applicable
- Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCCRecruitingNCT07397611Phase 2
- Iparomlimab and Tuvonralimab (QL1706) Combination With Lenvatinib as Neoadjuvant Therapy for ccRCCRecruitingNCT07389629Phase 2
- Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCCRecruitingNCT07386158Phase 2
- Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney CancerRecruitingNCT07383441Phase 3
- Sapu003 in Advanced mTOR-sensitive Solid TumorsRecruitingNCT07369505Phase 1
- Multi-omics Analysis of Renal Cell Carcinoma Mechanisms; Drug Sensitivity Testing in Patient-Derived Cell-based MicrotumorsNot yet recruitingNCT07351266
- Dynamic 82-Rb Positron Emission Tomography (PET) for the Grading of KIDney CarcinomaNot yet recruitingNCT07346404Phase 2
- The Cold Ischemia Robot-assisted Partial NephrectomyRecruitingNCT07326280Not applicable
- Radical Nephrectomy With vs Without Template Lymph Node Dissection in High-Risk Renal Cell Carcinoma (T-LND RCC)RecruitingNCT07321197Not applicable
- Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell CarcinomaRecruitingNCT07301827Not applicable
- Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell CarcinomaRecruitingNCT07300241Phase 1
- GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid TumoursRecruitingNCT07297667Phase 1
- Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After NephrectomyRecruitingNCT07294859
- A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)RecruitingNCT07293351Phase 1/2
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasRecruitingNCT07285044Phase 2
- Iparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic TherapyNot yet recruitingNCT07277972Phase 2
- A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver SpreadNot yet recruitingNCT07256223Phase 2
- Study of ACC-1898 in Adult Participants With Advanced Solid TumorsNot yet recruitingNCT07252661Phase 1
- Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry AnalysisNot yet recruitingNCT07246759
- Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney CancerNot yet recruitingNCT07243067
- Abscopal Effect of Ultra-Hypofractionated Radiation Plus Immunotherapy in Metastatic Renal Cell CarcinomaRecruitingNCT07240610
- Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney CancerRecruitingNCT07234656
- Immediate Versus Deferred Cytoreductive Nephrectomy With Ipilimumab/Nivolumab in mRCCNot yet recruitingNCT07233668Not applicable
- Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell CancerRecruitingNCT07227415Phase 1/2
- A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)RecruitingNCT07227402Phase 3
- Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell CancerRecruitingNCT07226544Phase 2
- Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell CarcinomaRecruitingNCT07223541Phase 2
- Patient Preference for Subcutaneous vs. Intravenous Immune TherapyRecruitingNCT07223424Phase 2
- Retifanlimab and Ruxolitinib In Solid MalignanciesRecruitingNCT07219576Phase 1/2